New Delhi, Jul 31 (PTI) Clinical trials conducted by a Delhi-based cancer hospital using a surgical robotic system enabled doctors to perform surgeries remotely, it said on Wednesday.

The trial using the SSI Mantra Surgical Robotic System was conducted at the Rajiv Gandhi Cancer Institute and Research Centre.

Also Read | Shillong Teer Results Today, July 31 2024: Check Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

"One of the most significant advantages of telesurgery is that superspecialists do not have to be physically present at the surgery location," said Sudhir Rawal, medical director and chief of genito-uro oncology at the institute.

"Any qualified surgeon can manage the surgery in the operating theatre while the superspecialists perform the surgery remotely," he said.

Also Read | What Regulations Does Delhi Government Want To Bring for Coaching Centres After 3 IAS Aspirants' Deaths?.

All six surgeries, including procedures for urinary bladder carcinoma, nephrectomy, hysterectomy and cystectomy, demonstrated the efficacy and safety of remote surgical practices and were completed without technical or surgical complications, Rawal said.

He also praised the integration of cutting-edge technology in patient care and said, "This innovation not only reduces travel cost for medical professionals but also lowers hospitalisation expenses for patients, particularly in tier 2 and 3 cities, where specialised medical care is often limited."

The initial telesurgery was performed in collaboration with SS Innovations, which made the robotic system. PTI

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)